Abstract
Summary of Key Points
- Current obesity policy fails to address stigma, accessibility, and sustained behavioural support.
- Community pharmacy is an underutilised, low-barrier setting for equitable weight management support.
- Digital peer support, when moderated by trained professionals, enhances motivation and engagement.
- Pharmacists play a critical role in reducing misuse of OTC weight loss products and guiding safe alternatives.
- GLP-1 agonists (e.g. Wegovy) present opportunities and risks; community pharmacy can support safe use and behaviour change alongside pharmacotherapy.
- Future policy must integrate behavioural, digital, and community-based interventions for sustained impact.
- Current obesity policy fails to address stigma, accessibility, and sustained behavioural support.
- Community pharmacy is an underutilised, low-barrier setting for equitable weight management support.
- Digital peer support, when moderated by trained professionals, enhances motivation and engagement.
- Pharmacists play a critical role in reducing misuse of OTC weight loss products and guiding safe alternatives.
- GLP-1 agonists (e.g. Wegovy) present opportunities and risks; community pharmacy can support safe use and behaviour change alongside pharmacotherapy.
- Future policy must integrate behavioural, digital, and community-based interventions for sustained impact.
| Original language | English |
|---|---|
| Place of Publication | London, U.K. |
| Publisher | UK Parliament |
| Number of pages | 4 |
| DOIs | |
| Publication status | Published - 29 Oct 2025 |
Fingerprint
Dive into the research topics of 'Written evidence submitted by Dr Philip Crilly at Kingston University London - FWM0007'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver